Join
Elanco Animal Health Incorporated logo

ELAN

NYSE

Elanco Animal Health Incorporated

SectorHealth CareIndustryBiotechnology: Pharmaceutical PreparationsIPO2018
$23.61-1.09 (-4.41%)
News25/Ratings12

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as functional nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations in approximately 90 countries in North America, Europe, the Middle East, Africa, Latin America, and the Asia-Pacific. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Price$23.61-0.83 (-3.40%)
2026-03-042026-06-05
News · 26 weeks112+40%
2025-12-14: 72025-12-21: 12025-12-28: 32026-01-04: 22026-01-11: 42026-01-18: 32026-01-25: 32026-02-01: 12026-02-08: 52026-02-15: 12026-02-22: 62026-03-01: 212026-03-08: 42026-03-15: 02026-03-22: 42026-03-29: 12026-04-05: 82026-04-12: 22026-04-19: 42026-04-26: 22026-05-03: 62026-05-10: 32026-05-17: 42026-05-24: 122026-05-31: 52026-06-07: 0
2025-12-142026-06-07
Mix5590d
  • Insider34(62%)
  • Other12(22%)
  • SEC Filings5(9%)
  • Earnings2(4%)
  • Analyst1(2%)
  • Leadership1(2%)

Latest news

25 items

ELAN FAQ

7 questions
  • What does Elanco Animal Health Incorporated do?
    Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and...
  • Where does ELAN stock trade?
    Elanco Animal Health Incorporated (ELAN) is listed on NYSE.
  • What sector and industry is ELAN in?
    Elanco Animal Health Incorporated operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.
  • When did Elanco Animal Health Incorporated go public?
    Elanco Animal Health Incorporated (ELAN) completed its IPO in 2018.
  • What are analysts saying about ELAN?
    Elanco Animal Health Incorporated has had 8 recent analyst actions on file. The most recent action was from Citigroup: Buy with a $3000.00 price target on 2026-04-15. Recent price targets range from $1800.00 to $3000.00.
  • What companies are similar to ELAN?
    Notable peers in the same industry include LLY (Eli Lilly and Company), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare ELAN side-by-side with any of them on Quantisnow.
  • How can I track ELAN on Quantisnow?
    Quantisnow aggregates Elanco Animal Health Incorporated's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ELAN to receive live email and push alerts on every new disclosure.